CNBC March 21, 2019
Tyler Clifford

  • “Being able to reduce those unnecessary [health care] costs, you know, the value created is going to start with a ‘b’ as in billion. That’s the opportunity that’s in front of us,” CVS CEO Larry Merlo says.
  • “As we think about this new company [with Aetna], we’re gonna manage it at an enterprise level,” he tells CNBC’s Jim Cramer.
  • CVS has added CBD oil products to store shelves in eight states, he says.

CVS Health CEO Larry Merlo told CNBC Thursday that the health chain is unlocking growth opportunities despite the stock’s downward trend...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Healthcare System, Insurance, Market Research, Payer, Pharma, Provider, Retail care, Trends
ASHP to CMS: 'Change course' on drug pricing
Many independent pharmacists will not stock drugs in the price negotiation program
Measuring Progress for Life Sciences: Trust, Patient Access, and Prevention at a Fork in the Road of Public Health
2025 Pharma Forecast: Four Pivotal Trends Revolutionizing Market Access Strategies
Christophe Weber, veteran Takeda CEO, to retire next year

Share This Article